Philip Morris International (PM) Q3 2026 Earnings Call: Q&A Summary

Q: Bonnie Herzog from Goldman Sachs asked why guidance for organic operating income and EPS was moved to the middle or lower half of the range despite a better Q3, whether higher spending and strategic initiatives like 20-pouch cans in the U.S. are driving this, and how to think about U.S. profitability and EPS growth next year.

A: Massimo Andolina (Group Chief Financial Officer) answered that the guidance adjustment is driven primarily by geopolitical cost pressures and one-off supply chain destruction in Ukraine from bombing, which together account for about 1 point of EPS impact. He detailed that U.S. investments are exceptional due to transitioning flagship variants from 15 to 20 pouches at the same price (a 25% price reduction per pouch), trade support for existing 15-pouch cans, and a projected 10% sequential increase in Q4 SG&A over the $370 million spent in Q3 to support brand awareness and the expanded portfolio. He added that Q3 spending levels serve as a good run-rate proxy for next year.

Q: Bonnie Herzog from Goldman Sachs asked for feedback on recent ZYN innovations relative to internal expectations and how the move to 20 pouches per can might impact consumer behavior and volumes.

A: Massimo Andolina answered that initial consumer and retail reactions to the dry flavor expansions and higher nicotine Ultra variants (9 and 11 milligrams) have been overwhelmingly positive, attracting new legal-age smokers and bringing back consumers who had moved to competitors. Regarding 20-pouch cans, he stated that having more product on hand tends to increase average daily consumption over time as consumers stay in the category.

Q: Matt Smith from Stifel asked if the Q4 impact from geopolitical inflation would exceed a 1-point drag on profit and how management views levers like cost savings and pricing to offset these impacts.

A: Massimo Andolina stated that geopolitical conflict in the Middle East is driving energy and service cost inflation that flows into the second half, with Q4 seeing the highest impact from a timing perspective. He highlighted that PMI's globally sourced materials and supply chain protections limit their impact compared to peers, and noted that strong year-to-date margin expansion and pricing power leave them well positioned entering 2027.

Q: Matt Smith from Stifel asked about the change in guidance where IQOS shipments are expected to slightly trail IMS growth and whether exiting 2026 inventory levels are normal.

A: Massimo Andolina explained that due to two tax-driven price increases in Japan this year, shipments and IMS diverged because of consumer pantry loading in H1 ahead of the April price change. With a smaller October price increase of JPY 20, less pantry loading occurred in H2, allowing IMS to run slightly ahead of shipments and inventories to normalize.

Q: Eric Serotta from Morgan Stanley asked about major puts and takes for international smoke-free growth next year, including tax and regulatory expectations in Japan and other markets.

A: Massimo Andolina highlighted that IMS momentum is broadening globally, with double-digit growth across multiple large markets. He noted that Japan's 2027 excise calendar involves a more moderate, uniform JPY 12 increase across both HTUs and cigarettes, reducing shock compared to the asymmetric increases of 2026, and pointed to growth from the rollout of BONDS by IQOS and new market entry steps in Argentina.

Q: Eric Serotta from Morgan Stanley asked what drove the softer implied price mix in international smoke-free during the third quarter.

A: Massimo Andolina attributed the softer third-quarter price mix to shipment volume comparisons against the prior year and the timing of certain pricing decisions within IQOS.

Q: Pallav Mittal from Barclays asked whether U.S. EBIT would decline next year given that investments will continue.

A: Massimo Andolina declined to give direct guidance for next year but noted that nicotine pouch volumes have grown for three consecutive quarters, category growth is strong, and Q3 cost levels serve as a proxy for next year. He explained that as volume growth continues and manufacturing facilities like the one in Colorado absorb overheads, the absorption of costs will improve despite the 25% price optimization lagging revenues for three quarters.

Q: Andrei Andon-Ionita from Jefferies asked how the newly passed sharp excise tax increases in Germany will affect combustibles and heated tobacco volumes and pricing in 2027 and beyond.

A: Massimo Andolina acknowledged that large tax increases generally shift volume to illicit players and reduce government tax collection, but emphasized that PMI is well prepared with strong brand equity in Marlboro and L&M, alongside tiered offerings like Marlboro Crafted. He added that heated tobacco preserves its tax differential over cigarettes, supporting continued IQOS growth.

Q: Andrei Andon-Ionita from Jefferies asked if the 4.2% U.S. ZYN shipment growth in Q3 was driven by restocking compared to third-party scanner data.

A: Massimo Andolina clarified that Q3 shipments grew 4.2% as reported, and when removing the unfavorable comparison from nicotine pouch promotions in September 2025, shipment growth was 13%. He noted that shipments were also supported by distribution buildout and pipelining for the newly launched variant expansions.